Stock listing

GH Stock Price, News, Filings & Events — Guardant Health, Inc.

Selected listing: GH · NASDAQ · USD · US

This page tracks Guardant Health, Inc.'s GH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GH:NASDAQ. GH:NASDAQ is the stock-level entry point for investors researching Guardant Health, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Guardant Health, Inc. is a publicly traded company listed under the ticker GH, operating in the American market. The company has a market capitalization of approximately $19.54 billion. Guardant Health specializes in advanced genomic testing for cancer, focusing on non-invasive blood tests to help guide treatment decisions.

GH:NASDAQUSDUSUpdated July 24, 2026
Guardant Health, Inc. logo
Ticker
GH:NASDAQ
Asset type
Stock
Market cap
$19.54B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD

Guardant Health, Inc. GH:NASDAQ stock context

This page tracks Guardant Health, Inc.'s GH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GH:NASDAQ. GH:NASDAQ is the stock-level entry point for investors researching Guardant Health, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Guardant Health, Inc. is a publicly traded company listed under the ticker GH, operating in the American market. The company has a market capitalization of approximately $19.54 billion. Guardant Health specializes in advanced genomic testing for cancer, focusing on non-invasive blood tests to help guide treatment decisions.

Research Guardant Health, Inc.

Alternate listings